Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
intraokulær opløsning |
Is a |
False |
Conventional release eye solution (dose form) |
Inferred relationship |
Some |
|
Eye drops solution |
Is a |
False |
Conventional release eye solution (dose form) |
Inferred relationship |
Some |
|
dexamethasonnatriumphosphat 0,1 mg/ml opløsning |
Has manufactured dose form |
False |
Conventional release eye solution (dose form) |
Inferred relationship |
Some |
|
Naphazoline hydrochloride 250 microgram/mL and pheniramine maleate 3 mg/mL eye solution |
Has manufactured dose form |
True |
Conventional release eye solution (dose form) |
Inferred relationship |
Some |
|
Product containing precisely brimonidine tartrate 1 milligram/1 milliliter conventional release eye solution (clinical drug) |
Has manufactured dose form |
True |
Conventional release eye solution (dose form) |
Inferred relationship |
Some |
|
polymyxin B-sulfat + trimethoprimsulfat 10.000 enheder/1 mg opløsning til oftalmisk anvendelse |
Has manufactured dose form |
False |
Conventional release eye solution (dose form) |
Inferred relationship |
Some |
|
ketorolactrometamol 0,5 % opløsning til oftalmisk anvendelse |
Has manufactured dose form |
False |
Conventional release eye solution (dose form) |
Inferred relationship |
Some |
|
Product containing precisely cromoglicate sodium 40 milligram/1 milliliter conventional release eye solution (clinical drug) |
Has manufactured dose form |
True |
Conventional release eye solution (dose form) |
Inferred relationship |
Some |
|
Product containing precisely azelastine hydrochloride 500 microgram/1 milliliter conventional release eye solution (clinical drug) |
Has manufactured dose form |
True |
Conventional release eye solution (dose form) |
Inferred relationship |
Some |
|
azithromycin 1 % opløsning til oftalmisk anvendelse |
Has manufactured dose form |
False |
Conventional release eye solution (dose form) |
Inferred relationship |
Some |
|
Product containing precisely gatifloxacin 3 milligram/1 milliliter conventional release eye solution (clinical drug) |
Has manufactured dose form |
True |
Conventional release eye solution (dose form) |
Inferred relationship |
Some |
|
Idoxuridine 1 mg/mL eye solution |
Has manufactured dose form |
True |
Conventional release eye solution (dose form) |
Inferred relationship |
Some |
|
Sodium chloride 50 mg/mL eye solution |
Has manufactured dose form |
True |
Conventional release eye solution (dose form) |
Inferred relationship |
Some |
|
Product containing precisely hydroxyamfetamine hydrobromide 10 milligram/1 milliliter and tropicamide 2.5 milligram/1 milliliter conventional release eye solution (clinical drug) |
Has manufactured dose form |
True |
Conventional release eye solution (dose form) |
Inferred relationship |
Some |
|
Product containing precisely olopatadine (as olopatadine hydrochloride) 2 milligram/1 milliliter conventional release eye solution (clinical drug) |
Has manufactured dose form |
True |
Conventional release eye solution (dose form) |
Inferred relationship |
Some |
|
Product containing precisely ketorolac trometamol 4 milligram/1 milliliter conventional release eye solution (clinical drug) |
Has manufactured dose form |
True |
Conventional release eye solution (dose form) |
Inferred relationship |
Some |
|
Sulfafurazole 40 mg/mL eye solution |
Has manufactured dose form |
True |
Conventional release eye solution (dose form) |
Inferred relationship |
Some |
|
moxifloxacinhydrochlorid 0,5 % opløsning til oftalmisk anvendelse |
Has manufactured dose form |
False |
Conventional release eye solution (dose form) |
Inferred relationship |
Some |
|
Trypan blue 1.5mg/mL ophthalmic solution |
Has manufactured dose form |
False |
Conventional release eye solution (dose form) |
Inferred relationship |
Some |
|
ketorolactrometamol 0,5 % opløsning uden konserveringsmiddel til oftalmisk anvendelse |
Has manufactured dose form |
False |
Conventional release eye solution (dose form) |
Inferred relationship |
Some |
|
Brimonidine tartrate 1.5 mg/mL eye solution |
Has manufactured dose form |
True |
Conventional release eye solution (dose form) |
Inferred relationship |
Some |
|
levofloxacin 5mg/ml oftalmisk opløsning |
Has manufactured dose form |
False |
Conventional release eye solution (dose form) |
Inferred relationship |
Some |
|
0,06 opløsning med trypanblåt til oftalmisk anvendelse |
Has manufactured dose form |
False |
Conventional release eye solution (dose form) |
Inferred relationship |
Some |
|
benoxinathydrochlorid + fluoresceinnatrium 0,4 %/0,25 % opløsning til oftalmisk anvendelse |
Has manufactured dose form |
False |
Conventional release eye solution (dose form) |
Inferred relationship |
Some |
|
Product containing precisely sodium chloride 20 milligram/1 milliliter conventional release eye solution (clinical drug) |
Has manufactured dose form |
True |
Conventional release eye solution (dose form) |
Inferred relationship |
Some |
|
Dorzolamide (as dorzolamide hydrochloride) 20 mg/mL eye solution |
Has manufactured dose form |
True |
Conventional release eye solution (dose form) |
Inferred relationship |
Some |
|
Unoprostone isopropyl 1.5 mg/mL eye solution |
Has manufactured dose form |
True |
Conventional release eye solution (dose form) |
Inferred relationship |
Some |
|
gentamicinsulfat 0,3 % opløsning til oftalmisk anvendelse |
Has manufactured dose form |
False |
Conventional release eye solution (dose form) |
Inferred relationship |
Some |
|
levofloxacin 1,5 % opløsning til oftalmisk anvendelse |
Has manufactured dose form |
False |
Conventional release eye solution (dose form) |
Inferred relationship |
Some |
|
Product containing precisely bepotastine besilate 15 milligram/1 milliliter conventional release eye solution (clinical drug) |
Has manufactured dose form |
True |
Conventional release eye solution (dose form) |
Inferred relationship |
Some |
|
Product containing precisely ketorolac trometamol 4.5 milligram/1 milliliter conventional release eye solution (clinical drug) |
Has manufactured dose form |
True |
Conventional release eye solution (dose form) |
Inferred relationship |
Some |
|
bromfenac 0,09 % opløsning til oftalmisk anvendelse |
Has manufactured dose form |
False |
Conventional release eye solution (dose form) |
Inferred relationship |
Some |
|
timololmaleat 0,25% oftalmisk opløsning |
Has manufactured dose form |
False |
Conventional release eye solution (dose form) |
Inferred relationship |
Some |
|
diclofenacnatrium 0,1 % oftalmisk opløsning |
Has manufactured dose form |
False |
Conventional release eye solution (dose form) |
Inferred relationship |
Some |
|
Tobramycin 3 mg/mL eye solution |
Has manufactured dose form |
True |
Conventional release eye solution (dose form) |
Inferred relationship |
Some |
|
timololmaleat 0,5 % geldannende opløsning til oftalmisk anvendelse |
Has manufactured dose form |
False |
Conventional release eye solution (dose form) |
Inferred relationship |
Some |
|
timololmaleat 0,25 % geldannende opløsning til oftalmisk anvendelse |
Has manufactured dose form |
False |
Conventional release eye solution (dose form) |
Inferred relationship |
Some |
|
pheniramin 0,0315 % + naphazolin 0,02675 % opløsning til oftalmisk anvendelse |
Has manufactured dose form |
False |
Conventional release eye solution (dose form) |
Inferred relationship |
Some |
|
timololmaleat 0,5 % oftalmisk opløsning |
Has manufactured dose form |
False |
Conventional release eye solution (dose form) |
Inferred relationship |
Some |
|
Gatifloxacin 5 mg/mL eye solution |
Has manufactured dose form |
True |
Conventional release eye solution (dose form) |
Inferred relationship |
Some |
|
Alcaftadine 2.5 mg/mL eye solution |
Has manufactured dose form |
True |
Conventional release eye solution (dose form) |
Inferred relationship |
Some |
|
Product containing precisely pilocarpine hydrochloride 80 milligram/1 milliliter conventional release eye solution (clinical drug) |
Has manufactured dose form |
True |
Conventional release eye solution (dose form) |
Inferred relationship |
Some |
|
Tetracaine hydrochloride 5 mg/mL cutaneous solution |
Has manufactured dose form |
False |
Conventional release eye solution (dose form) |
Inferred relationship |
Some |
|
Product containing precisely pilocarpine hydrochloride 2.5 milligram/1 milliliter conventional release eye solution (clinical drug) |
Has manufactured dose form |
True |
Conventional release eye solution (dose form) |
Inferred relationship |
Some |
|
norfloxacin 0,3 % opløsning |
Has manufactured dose form |
False |
Conventional release eye solution (dose form) |
Inferred relationship |
Some |
|
Product containing precisely pilocarpine hydrochloride 100 milligram/1 milliliter conventional release eye solution (clinical drug) |
Has manufactured dose form |
True |
Conventional release eye solution (dose form) |
Inferred relationship |
Some |
|
diclofenacnatrium 0,1 % øjendråber til engangsbrug |
Has manufactured dose form |
False |
Conventional release eye solution (dose form) |
Inferred relationship |
Some |
|
diclofenacnatrium 0,1 % øjendråber med flere doser |
Has manufactured dose form |
False |
Conventional release eye solution (dose form) |
Inferred relationship |
Some |
|
Phenylephrine hydrochloride 100 mg/mL eye solution |
Has manufactured dose form |
True |
Conventional release eye solution (dose form) |
Inferred relationship |
Some |
|
adrenalinhydrochlorid 1 % opløsning |
Has manufactured dose form |
False |
Conventional release eye solution (dose form) |
Inferred relationship |
Some |
|
adrenalinhydrochlorid 2 % opløsning |
Has manufactured dose form |
False |
Conventional release eye solution (dose form) |
Inferred relationship |
Some |
|
adrenalin 2,0 % opløsning |
Has manufactured dose form |
False |
Conventional release eye solution (dose form) |
Inferred relationship |
Some |
|
Adrenaline 5 mg/mL eye solution |
Has manufactured dose form |
True |
Conventional release eye solution (dose form) |
Inferred relationship |
Some |
|
adrenalin 1,0 % opløsning |
Has manufactured dose form |
False |
Conventional release eye solution (dose form) |
Inferred relationship |
Some |
|
Naphazoline hydrochloride 1 mg/mL eye solution |
Has manufactured dose form |
True |
Conventional release eye solution (dose form) |
Inferred relationship |
Some |
|
prednisolonnatriumphosphat 1 % opløsning |
Has manufactured dose form |
False |
Conventional release eye solution (dose form) |
Inferred relationship |
Some |
|
phenylephrinhydrochlorid 2,5 % opløsning |
Has manufactured dose form |
False |
Conventional release eye solution (dose form) |
Inferred relationship |
Some |
|
Dexamethasone 1 mg/mL cutaneous solution |
Has manufactured dose form |
False |
Conventional release eye solution (dose form) |
Inferred relationship |
Some |
|
prednisolonnatriumphosphat 1/8 % opløsning |
Has manufactured dose form |
False |
Conventional release eye solution (dose form) |
Inferred relationship |
Some |
|
Product containing precisely pemirolast potassium 1 milligram/1 milliliter conventional release eye solution (clinical drug) |
Has manufactured dose form |
True |
Conventional release eye solution (dose form) |
Inferred relationship |
Some |
|
Product containing precisely cyclopentolate hydrochloride 2 milligram/1 milliliter and phenylephrine hydrochloride 10 milligram/1 milliliter conventional release eye solution (clinical drug) |
Has manufactured dose form |
True |
Conventional release eye solution (dose form) |
Inferred relationship |
Some |
|
adrenalinbitartrat 1 % wt/vol + pilocarpinhydrochlorid 1 % wt/vol opløsning |
Has manufactured dose form |
False |
Conventional release eye solution (dose form) |
Inferred relationship |
Some |
|
adrenalinbitartrat 1 % wt/vol + pilocarpinhydrochlorid 4 % wt/vol opløsning |
Has manufactured dose form |
False |
Conventional release eye solution (dose form) |
Inferred relationship |
Some |
|
adrenalinbitartrat 1 % + pilocarpinhydrochlorid 6 % wt/vol opløsning |
Has manufactured dose form |
False |
Conventional release eye solution (dose form) |
Inferred relationship |
Some |
|
adrenalinbitartrat 1 % wt/vol + pilocarpinhydrochlorid 2 % wt/vol opløsning |
Has manufactured dose form |
False |
Conventional release eye solution (dose form) |
Inferred relationship |
Some |
|
Product containing precisely naphazoline hydrochloride 200 microgram/1 milliliter conventional release eye solution (clinical drug) |
Has manufactured dose form |
True |
Conventional release eye solution (dose form) |
Inferred relationship |
Some |
|
Product containing precisely naphazoline hydrochloride 300 microgram/1 milliliter conventional release eye solution (clinical drug) |
Has manufactured dose form |
True |
Conventional release eye solution (dose form) |
Inferred relationship |
Some |
|
Cocaine hydrochloride 2.5% conventional release eye solution |
Has manufactured dose form |
False |
Conventional release eye solution (dose form) |
Inferred relationship |
Some |
|
Ketorolac trometamol 0.5% conventional release eye solution |
Has manufactured dose form |
False |
Conventional release eye solution (dose form) |
Inferred relationship |
Some |
|
Diclofenac sodium 0.1% conventional release eye drops |
Has manufactured dose form |
False |
Conventional release eye solution (dose form) |
Inferred relationship |
Some |
|
Cocaine hydrochloride 10% conventional release eye solution |
Has manufactured dose form |
False |
Conventional release eye solution (dose form) |
Inferred relationship |
Some |
|
Diclofenac sodium 0.1% conventional release solution for eye drops |
Has manufactured dose form |
False |
Conventional release eye solution (dose form) |
Inferred relationship |
Some |
|
Product containing precisely sulfacetamide sodium 100 milligram/1 milliliter conventional release eye solution (clinical drug) |
Has manufactured dose form |
True |
Conventional release eye solution (dose form) |
Inferred relationship |
Some |
|
Sulfacetamide sodium 150 mg/mL eye solution |
Has manufactured dose form |
True |
Conventional release eye solution (dose form) |
Inferred relationship |
Some |
|
Hydrocortisone 10 mg/mL eye solution |
Has manufactured dose form |
True |
Conventional release eye solution (dose form) |
Inferred relationship |
Some |
|
Product containing precisely sulfacetamide sodium 300 milligram/1 milliliter conventional release eye solution (clinical drug) |
Has manufactured dose form |
True |
Conventional release eye solution (dose form) |
Inferred relationship |
Some |
|
Dexamethasone 1 mg/mL and hypromellose 5 mg/mL eye solution |
Has manufactured dose form |
True |
Conventional release eye solution (dose form) |
Inferred relationship |
Some |
|
Naphazoline hydrochloride 270 microgram/mL and pheniramine maleate 3.15 mg/mL eye solution |
Has manufactured dose form |
True |
Conventional release eye solution (dose form) |
Inferred relationship |
Some |
|
Product containing precisely proparacaine hydrochloride 5 milligram/1 milliliter conventional release eye solution (clinical drug) |
Has manufactured dose form |
False |
Conventional release eye solution (dose form) |
Inferred relationship |
Some |
|
Prednisolone (as prednisolone sodium phosphate) 5 mg/mL eye solution |
Has manufactured dose form |
True |
Conventional release eye solution (dose form) |
Inferred relationship |
Some |
|
Product containing precisely prednisolone 1.25 milligram/1 milliliter conventional release eye solution (clinical drug) |
Has manufactured dose form |
True |
Conventional release eye solution (dose form) |
Inferred relationship |
Some |
|
Product containing precisely prednisolone (as prednisolone sodium phosphate) 300 microgram/1 milliliter conventional release eye solution (clinical drug) |
Has manufactured dose form |
True |
Conventional release eye solution (dose form) |
Inferred relationship |
Some |
|
Product containing precisely prednisolone 10 milligram/1 milliliter conventional release eye solution (clinical drug) |
Has manufactured dose form |
False |
Conventional release eye solution (dose form) |
Inferred relationship |
Some |
|
Product containing precisely methacholine 25 milligram/1 milliliter conventional release eye solution (clinical drug) |
Has manufactured dose form |
True |
Conventional release eye solution (dose form) |
Inferred relationship |
Some |
|
Prednisolone (as prednisolone sodium phosphate) 1 mg/mL eye solution |
Has manufactured dose form |
True |
Conventional release eye solution (dose form) |
Inferred relationship |
Some |
|
Sulfacetamide sodium 200 mg/mL eye solution |
Has manufactured dose form |
True |
Conventional release eye solution (dose form) |
Inferred relationship |
Some |
|
Prednisolone (as prednisolone sodium phosphate) 100 microgram/mL eye solution |
Has manufactured dose form |
True |
Conventional release eye solution (dose form) |
Inferred relationship |
Some |
|
Dipivefrine hydrochloride 1 mg/mL eye solution |
Has manufactured dose form |
True |
Conventional release eye solution (dose form) |
Inferred relationship |
Some |
|
Product containing precisely sucrose 300 milligram/1 milliliter conventional release eye solution (clinical drug) |
Has manufactured dose form |
True |
Conventional release eye solution (dose form) |
Inferred relationship |
Some |
|
Product containing precisely dexamethasone 1 milligram/1 milliliter conventional release eye solution (clinical drug) |
Has manufactured dose form |
False |
Conventional release eye solution (dose form) |
Inferred relationship |
Some |
|
Prednisolone (as prednisolone sodium phosphate) 10 microgram/mL eye solution |
Has manufactured dose form |
True |
Conventional release eye solution (dose form) |
Inferred relationship |
Some |
|
Homatropine hydrobromide 5 mg/mL eye solution |
Has manufactured dose form |
True |
Conventional release eye solution (dose form) |
Inferred relationship |
Some |
|
Product containing precisely flurbiprofen sodium 300 microgram/1 milliliter conventional release eye solution (clinical drug) |
Has manufactured dose form |
True |
Conventional release eye solution (dose form) |
Inferred relationship |
Some |
|
Product containing precisely homatropine hydrobromide 1.25 milligram/1 milliliter conventional release eye solution (clinical drug) |
Has manufactured dose form |
True |
Conventional release eye solution (dose form) |
Inferred relationship |
Some |
|
Chloramphenicol (as chloramphenicol sodium succinate) 2.5 mg/mL eye solution |
Has manufactured dose form |
True |
Conventional release eye solution (dose form) |
Inferred relationship |
Some |
|
Homatropine hydrobromide 50 mg/mL eye solution |
Has manufactured dose form |
True |
Conventional release eye solution (dose form) |
Inferred relationship |
Some |
|
Product containing precisely prednisolone (as prednisolone sodium phosphate) 30 microgram/1 milliliter conventional release eye solution (clinical drug) |
Has manufactured dose form |
True |
Conventional release eye solution (dose form) |
Inferred relationship |
Some |
|
Homatropine hydrobromide 2.5 mg/mL eye solution |
Has manufactured dose form |
True |
Conventional release eye solution (dose form) |
Inferred relationship |
Some |
|
Product containing precisely boric acid 10 milligram/1 milliliter conventional release eye solution (clinical drug) |
Has manufactured dose form |
True |
Conventional release eye solution (dose form) |
Inferred relationship |
Some |
|
Product containing precisely fluorescein sodium stain 2.5 milligram/1 milliliter and proxymetacaine hydrochloride 5 milligram/1 milliliter conventional release eye solution (clinical drug) |
Has manufactured dose form |
True |
Conventional release eye solution (dose form) |
Inferred relationship |
Some |
|
Cocaine (as cocaine hydrochloride) 20 mg/mL and homatropine hydrobromide 20 mg/mL eye solution |
Has manufactured dose form |
True |
Conventional release eye solution (dose form) |
Inferred relationship |
Some |
|